Which of the following is a potential undesirable consequence of inappropriate antibiotic use? A. Adverse drug reaction. B. Superinfection. C. Unnecessary selective pressure increasing antimicrobial resistance. D. All of the above.
Reading File
Finding Sources
Searching the Web
consequences of inappropriate antibiotic use adverse reactions superinfection antimicrobial resistance
Finding Sources
Answer: D. All of the above
The correct answer is D, and this is well-supported by both clinical evidence and authoritative sources. Inappropriate antibiotic use carries all three of these potential consequences simultaneously:
A. Adverse Drug Reactions (ADRs)
Antibiotics account for roughly 20% of all drug-related emergency department visits in the United States, with nearly 80% of those visits attributable to allergic reactions (PMC review). Side effects range from mild (nausea, vomiting, diarrhea, rash) to severe and life-threatening (anaphylaxis, C. difficile colitis, neurologic/psychiatric effects). When antibiotics are used inappropriately - for viral infections, for example - patients are exposed to all these risks with zero therapeutic benefit.
B. Superinfection
A superinfection is a new, secondary infection arising during or after antibiotic therapy, caused by organisms that flourish when the normal flora is disrupted. Common examples:
- Clostridioides difficile (pseudomembranous colitis) - particularly with broad-spectrum antibiotics
- Candida species (oral thrush, vaginal candidiasis)
- Drug-resistant bacteria that emerge when sensitive competing flora are wiped out
Textbooks confirm that superinfection is a recognized complication of antibiotic use across multiple clinical settings (Rosen's Emergency Medicine; Harrison's Principles of Internal Medicine).
C. Selective Pressure and Antimicrobial Resistance (AMR)
Every dose of antibiotic exerts selective pressure on microbial populations - bacteria with resistance mechanisms survive and replicate while susceptible ones are killed. Inappropriate or unnecessary use accelerates this at both individual and community levels. This has contributed to the global rise of multidrug-resistant organisms (MDROs). The CDC explicitly identifies unnecessary antibiotic use as a primary driver of AMR, which causes infections that are increasingly difficult - and sometimes impossible - to treat.
Key Takeaway
All three consequences (ADRs, superinfection, and AMR) are well-established, non-speculative harms of inappropriate antibiotic use. This is why antibiotic stewardship programs exist in healthcare systems worldwide - to ensure antibiotics are prescribed only when truly indicated, at the right dose, for the right duration, with the narrowest effective spectrum.
Antimicrobial Stewardship programs have been demonstrated to: A. Increase patient mortality. B. Reduce unnecessary antimicrobial use. C. Prolong ICU stays. D. Routinely override national guidelines for the management of infection.
Finding Sources
Searching PubMed
antimicrobial stewardship program outcomes
Reading File
Reading File
Answer: B. Reduce unnecessary antimicrobial use
This is the well-established, primary demonstrated benefit of Antimicrobial Stewardship Programs (ASPs). Here is a full breakdown:
Why B is correct
According to Harrison's Principles of Internal Medicine (22nd ed.), ASPs are designed to:
- Improve patient care through appropriate antimicrobial use
- Preserve a vital health resource by curbing resistance development
- Reduce adverse effects (including C. difficile infection)
- Control costs
Key ASP strategies - prospective audit with feedback, formulary restriction, and preauthorization - have been shown in multiple quasi-experimental studies to result in declines in broad-spectrum drug use and decreases in adverse events (Harrison's, p. 1223).
The Red Book (2021) similarly states: "The primary goal of antimicrobial stewardship is to optimize antimicrobial use with the aim of decreasing inappropriate use that leads to unwarranted toxicity and spread of resistant organisms."
Recent systematic reviews confirm this at a global level:
- A 2025 umbrella review (PMID: 40505966) confirmed that ASPs globally improve effectiveness, reduce resistance, and are cost-efficient.
- A 2022 meta-analysis (PMID: 35158078) found ASPs reduce inappropriate prescribing and resistance even in nursing home settings.
Why the other options are wrong
| Option | Why it is incorrect |
|---|---|
| A. Increase patient mortality | ASPs are associated with equal or improved patient outcomes, not increased mortality. Studies show no harm from appropriately implemented stewardship. |
| C. Prolong ICU stays | ASPs typically shorten hospital and ICU stays by optimizing therapy, enabling earlier de-escalation, and reducing complications like C. difficile. |
| D. Routinely override national guidelines | ASPs are built on national guidelines (CDC, TJC, CMS). They implement and reinforce guidelines rather than circumventing them. |
The CDC's 7 Core Elements of an ASP (for inpatient facilities)
- Hospital leadership commitment - dedicated resources and personnel
- Accountability - physician and pharmacy co-leaders
- Pharmacy expertise - ID-trained pharmacist involvement
- Action - prospective audit/feedback, preauthorization, guideline implementation
- Tracking - antibiotic use data monitored (days of therapy/1000 patient days)
- Reporting - regular updates on resistance and process measures
- Education - ongoing training of clinicians
ASPs represent a multidisciplinary, evidence-based approach that works with clinical teams to optimize prescribing - their demonstrated benefit is reducing unnecessary antimicrobial use without compromising patient safety.
This is a shared conversation. Sign in to Orris to start your own chat.